PBS re­forms to save $344m

Pharmacy Daily - - Front Page -

NEXT Mon’s lat­est round of changes to the Phar­ma­ceu­ti­cal Ben­e­fits Scheme is be­ing es­ti­mated at sav­ing Aus­tralian tax­pay­ers more than $344 mil­lion, with Health Min­is­ter Greg Hunt say­ing the changes will also pro­vide on­go­ing sup­port for the list­ing of more new medicines on the PBS.

Prices will be re­duced on a to­tal of 24 medicines, sold as a to­tal of 226 brands, with Hunt high­light­ing changes for non-con­ces­sional pa­tients such as pre­ga­balin which will cost $33.38 per script (a sav­ing of up to $6.12); val­sar­tan with hy­drochloroth­iazide for $23.96 (sav­ing $2.18); and dor­zo­lamide for $19.18 (a sav­ing of $3.02).

Yes­ter­day the Health Depart­ment made pub­lic the 01 Oct 2018 Price Dis­clo­sure Con­firmed Prices (see pbs.gov.au), which are the re­sult of the “Fifth Re­move Orig­i­na­tor Cy­cle” of the on­go­ing PBS re­form process.

Other items af­fected in this round in­clude nico­randil, capecitabine, frusemide, ade­fovir, azac­i­ti­dine, bleomycin, bosen­tan, en­te­cavir, ima­tin­imb, in­flix­imab, val­gan­ci­clovir and oxy­codone.

The Min­is­ter noted that al­most $10 bil­lion worth of new medicines had been sub­sidised since the gov­ern­ment came into power, with the depart­ment cur­rently mak­ing on av­er­age one new or amended PBS list­ing each day.

“Our com­mit­ment to the PBS is rock solid...to­gether with Medi­care it is the foun­da­tion of our world­class health care sys­tem,” he said.

The gov­ern­ment has es­ti­mated more than 800,000 Aus­tralians will ben­e­fit from Mon’s price cuts.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.